DCGI approves commercial launch of low cost Covid-19 test 'Feluda'

The Tata CRISPR test achieves accuracy levels of traditional RT-PCR tests with quicker turnaround time, less expensive equipment and better ease of use.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/35PVfTb
via IFTTT

0 comments:

Post a Comment